WHO Faces Financial Crisis as U.S. Pulls Funding
During the annual meeting of the World Health Organization (WHO) members in Geneva, Switzerland, concerns were raised about the potential disruption caused by the organization’s budget crisis. Officials and delegates discussed the possibility of program cuts that could lead to increased burden of disease and deaths worldwide.
The main source of financial difficulties for the WHO is the United States, which, under President Trump, is withdrawing its long-standing funding from the organization and other global health initiatives. This decision has put a strain on the WHO’s ability to carry out its global public health mission, as the U.S. has been a major sponsor of the organization for many years.
With the U.S. set to formally exit the WHO in 2026, the organization has had to cut its 2026–2027 budget by 20% to $4.2 billion. This withdrawal has opened the door for China to become the world’s largest funder of the WHO, with China announcing a $500 million donation to help fill the void left by the U.S.
To address the funding gap, the WHO is raising mandatory member contributions by 20% and has secured over $170 million in new commitments from various countries and organizations. Pharmaceutical company Novo Nordisk has also pledged almost $58 million through its philanthropy foundation to support the WHO’s efforts.
WHO’s Vital Role in Global Health
As a specialized agency of the United Nations, the WHO plays a crucial role in international public health. The organization coordinates with 194 member states on a wide range of public health activities, including managing disease outbreaks, vaccination campaigns, water sanitation projects, and support for countries facing health emergencies.
Since its establishment in 1948, the WHO has spearheaded numerous programs that have saved millions of lives. One of its major achievements was the global immunization campaign that led to the eradication of smallpox in 1980. The WHO Essential Medicines List, updated every two years, has also been a vital resource for nations in their medication procurement policies.
Furthermore, the WHO’s work on disease outbreaks, vaccination campaigns, and research on diseases like HIV, malaria, and tuberculosis has been instrumental in global health efforts. The organization’s efforts to address neglected tropical diseases (NTDs) have also been significant, with a roadmap outlining goals for prevention, treatment, and research in this area.
Challenges and Controversies
Despite its important work, the WHO has faced criticism and challenges. The U.S. decision to withdraw funding has raised concerns about the organization’s future operations. Some lawmakers have criticized the WHO for alleged political influence from certain member states, including China.
As the U.S. steps back from international health entities like the WHO, China is increasing its influence in global health policy. This shift in leadership roles has raised questions about the future direction of global health initiatives and the role of key stakeholders in shaping international public health efforts.
Overall, the WHO’s financial crisis and the changing dynamics of global health funding highlight the importance of international cooperation in addressing public health challenges and the need for sustainable funding mechanisms to support global health initiatives.
